Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruoxin Li

Showing results (61-70 of 64) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 64 results.
Nature Materials|May 29, 2025
Poly(carboxybetaine) lipids enhance mRNA therapeutics efficacy and reduce their immunogenicitySijin Luozhong, Pingchuan Liu, Ruoxin Li, et al.
Nature Biomedical Engineering|December 18, 2025
Low reactogenicity and high tumour antigen expression from mRNA-LNPs with membrane-destabilizing zwitterionic lipidsYu Zhao, Ruoxin Li, Pingchuan Liu, et al.
Science Translational Medicine|September 24, 2025
Progression to rheumatoid arthritis in at-risk individuals is defined by systemic inflammation and by T and B cell dysregulationZiyuan He, Marla C Glass, Pravina Venkatesan, et al.
Biorxiv : the Preprint Server for Biology|November 18, 2024
Systemic inflammation and lymphocyte activation precede rheumatoid arthritisZiyuan He, Marla C Glass, Pravina Venkatesan, et al.
Pageof 7

Showing results (61-70 of 64) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 64 results.
Nature Materials|May 29, 2025
Poly(carboxybetaine) lipids enhance mRNA therapeutics efficacy and reduce their immunogenicitySijin Luozhong, Pingchuan Liu, Ruoxin Li, et al.
Nature Biomedical Engineering|December 18, 2025
Low reactogenicity and high tumour antigen expression from mRNA-LNPs with membrane-destabilizing zwitterionic lipidsYu Zhao, Ruoxin Li, Pingchuan Liu, et al.
Science Translational Medicine|September 24, 2025
Progression to rheumatoid arthritis in at-risk individuals is defined by systemic inflammation and by T and B cell dysregulationZiyuan He, Marla C Glass, Pravina Venkatesan, et al.
Biorxiv : the Preprint Server for Biology|November 18, 2024
Systemic inflammation and lymphocyte activation precede rheumatoid arthritisZiyuan He, Marla C Glass, Pravina Venkatesan, et al.
Pageof 7